Garrett Winslow
General Counsel · Damora Therapeutics, Inc.
- 2024
- Jul 8, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Garrett Winslow files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jennifer Jarrett - $253K in DMRA purchases and sales in the last 12 months
- Hans T. Schambye - $15K in DMRA purchases and sales in the last 12 months
- Lori Firmani - $3K in DMRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Garrett Winslow?
Garrett Winslow is a corporate insider, tracked as General Counsel of Damora Therapeutics, Inc. (DMRA). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Garrett Winslow last file a Form 4?
The most recent primary Form 4 on record is dated 8 July 2026, one of 5 filings going back to 2024.
Has Garrett Winslow been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($14K) across all tracked filings.
